Species |
Human |
Protein Construction |
CD73 (Trp27-Lys547) Accession # P21589 |
Poly-His |
N-term |
C-term |
|
Purity |
> 95% as analyzed by SDS-PAGE > 95% as analyzed by HPLC |
Endotoxin Level |
≤ 1 EU/μg of protein by LAL method |
Biological Activity |
Immobilized Human CD73, His at 0.5 μg/ml (100 μl/Well). Dose response curve for Anti-CD73 Ab with the EC50 of 19.3 ng/ml determined by ELISA. |
Expression System |
Expi293 |
Apparent Molecular Weight |
~58.8 kDa, on SDS-PAGE under reducing conditions. |
Formulation |
Supplied as a 0.22 μm filtered solution in 20 mM Tris, 120 mM NaCl, 4 mM CaCl2, 20% glycerol, pH 7.5. |
Concentration |
Please refer to the COA for the specific lot. |
Storage & Stability |
Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Avoid repeated freeze-thaw cycles. |
The purity of Human CD73 is greater than 95% as determined by SEC-HPLC.
Immobilized Human CD73, His Tag at 0.5 μg/ml (100 μl/well). Dose response curve for Anti-CD73 Ab with the EC50 of 16.9 ng/ml determined by ELISA.
Human CD73 on SDS-PAGE under reducing conditions. The purity is greater than 95%.
Target Background |
CD73, also known as ecto-5'-nucleotidase, is an enzyme that in humans is encoded by the NT5E gene.CD73 commonly serves to convert AMP to adenosine.The enzyme consists of a dimer of 2 identical 70-kD subunits bound by a glycosyl phosphatidyl inositol linkage to the external face of the plasma membrane. The enzyme is used as a marker of lymphocyte differentiation. A deficiency of CD73 occurs in a variety of immunodeficiency diseases. |
Synonyms |
CD73 antigen; CD73; NT5E; NTE; 5' nucleotidase (CD73); 5'-NT; 5-NT; 5'-Nucleotidase; 5'-nucleotidase, ecto (CD73); E5NT; EC 3.1.3.5; ecto-5'-nucleotidase; eN; eNT; NT; NT55'-nucleotidase; Purine 5-Prime-Nucleotidase |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.